Home6185 • HKG
add
Cansino Biologics Inc
Previous close
$30.50
Day range
$28.50 - $30.80
Year range
$16.32 - $42.20
Market cap
10.12B HKD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 279.26M | 53.90% |
Operating expense | 642.61M | 25.88% |
Net income | -156.47M | 68.56% |
Net profit margin | -56.03 | 79.57% |
Earnings per share | — | — |
EBITDA | -156.97M | 82.50% |
Effective tax rate | 2.45% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.28B | -20.50% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 5.06B | — |
Shares outstanding | 249.18M | — |
Price to book | 1.48 | — |
Return on assets | — | — |
Return on capital | -7.57% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -156.47M | 68.56% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,105
